{"database": "lobbying", "table": "lobbying_activities", "rows": [[1984451, "28655048-411c-421a-9cbd-0faba9398dd3", "Q2", "RED+BLUE STRATEGIES", 400693064, "EXPRESS SCRIPTS INC.", 2017, "second_quarter", "MMM", "S. 637 - Creating Transparency to have Prescription Drug Rebates Unlocked - Issues related to the alleged relationship between rebates and drug prices.\n\nS. 771 - A bill to Improve Access to Affordable Prescription Drugs - Issue related to bringing drug pricing down including better policies in the Part D coverage gap, couponing and advancing biosimilars. \n\nIssues related to the price of prescription medications in the United States.", "Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2017-07-10T13:37:04.490000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1984451"], "units": {}, "query_ms": 62.410890008322895, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}